ACR Convergence 2026 Archives - ACR Meeting Abstracts

Abstract Number: 2963

Machine Learning for Risk Stratification After Primary Total Knee Arthroplasty
Abstract Number: 1021

Machine Learning-Based Automated Assessment of the Prognostic Utility of Glomerular Tuft Pathomics in Lupus Nephritis
Abstract Number: 1160

Machine Learning-Based Early Identification of ANCA-Associated Vasculitis Using Pre-Diagnostic Real-World Claims Data
Abstract Number: 2872

Machine Learning-Based Prediction of Quality of Life in Systemic Lupus Erythematosus Using Wearable Device-Derived Physiological Data
Abstract Number: 2754

Machine-Learning Approaches to Prediction of Metabolic Adverse Events in Patients with Rheumatoid Arthritis Initiating Glucocorticoids
Abstract Number: 2021

Macrophage dynamics in murine arthritis mirror human rheumatoid arthritis synovium: a preclinical platform for testing phase-specific macrophage-targeted therapies
Abstract Number: 2039

Macrophage subpopulations correlate with a failure to respond to therapy in a prospective, longitudinal study on RA patients
Abstract Number: 1967

Macrophage/DC subpopulations correlate with esophagus dysmotility in SSc patients.
Abstract Number: 0683

Magnitude and Phenotypic Patterns of Progression from Interstitial Pneumonia with Autoimmune Features to Systemic Autoimmune Rheumatic Disease: A Systematic Review and Meta-Analysis
Abstract Number: 1472

Maintenance of Prednisolone ≤5 mg/day During Pregnancy is Associated with Favorable Pregnancy Outcomes in Women with Systemic Lupus Erythematosus
Abstract Number: 1623

Malignancies in a Spanish Cohort of Patients with VEXAS Syndrome
Abstract Number: 0459

Malignancies Risk Between Non-TNFi Biologic Agents and JAKi in Rheumatoid Arthritis: A Systematic Review and Bayesian Network Meta-analysis
Abstract Number: 2074

Malondialdehyde-Acetaldehyde and Citrulline Co-Modified Fibrinogen Promotes DNA Hypomethylation in Macrophages
Abstract Number: 0730

Management of anti-TNF therapy in patients with leishmaniasis: is it necessary to suspend biological treatment?
Abstract Number: 2632

Management of Relapses after Autologous CD19 CAR T-Cell Therapy in SLE, SSc and IIM – a Case Series
Abstract Number: 1695

Manubriosternal joint structural changes on thoracic CT in radiographic and non-radiographic axial spondyloarthritis: a comparative study with controls
Abstract Number: 0960

Mapping Complement Activation in Giant Cell Arteritis
Abstract Number: 1161

Mapping Complement Activation Profiles in ANCA-Associated Vasculitides
Abstract Number: 2501

Mapping Disparities in Juvenile Dermatomyositis: A Retrospective Geospatial Study of Non-medical Drivers, Disease Presentation, and Clinical Course
Abstract Number: 2724

Mapping Practice Settings and Workforce Trends in U.S. Rheumatology
Abstract Number: 0149

Mapping The Cellular Organization Of The Human Spleen
Abstract Number: 0771

Mapping the Impact of Urban-Rural Classification on Systemic Lupus Erythematosus: Results from a Single Center Study
Abstract Number: 1473

Maternal and Fetal Outcomes Associated with Glucocorticoid Use During Pregnancy in Women with Rheumatic Diseases: A Canadian Registry Study
Abstract Number: 2460

Maternal Bleeding Risk at Delivery in SLE Pregnancies Receiving Antithrombotics
Abstract Number: 2502

Maternal Exposure to Harmful Substances and Risk of Juvenile Idiopathic Arthritis in the Child: Gene-Environment Interaction Analyses in a Norwegian Pregnancy Cohort
Abstract Number: 2461

Maternal Vascular Malperfusion Lesions of the Placenta Characterize Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus
Abstract Number: 2503

Maternal Weight and Hypertensive Disorders of Pregnancy as Risk Factors for Juvenile Idiopathic Arthritis in the Child: A Prospective Population-Based Pregnancy Cohort Study
Abstract Number: 2886

Matrix Metalloproteinase-7 Concentrations and Severity of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Number: 2370

May ultrasonography replace labial salivary gland biopsy and salivary gland flow rate assessment ?
Abstract Number: 0887

MDA5 multimerization on LINE RNA drives pathogenic extracellular immune complexes in dermatomyositis
Abstract Number: 1596

Measurement Properties and PROMIS Physical Function Crosswalk of the Health Assessment Questionnaire Disability Index in Adult Idiopathic Inflammatory Myopathies: A Longitudinal Validation Study from the MyoCite Registry
Abstract Number: 2594

Measurement Properties of PROMIS-29 for Health-Related Quality of Life Assessment in Adults with Inflammatory Myopathies
Abstract Number: 1726

Measuring Complete Lupus Nephritis Screening: A Population-Based Assessment of Renal Function and Urine Protein Testing in SLE
Abstract Number: 1138

Mechanistic Modeling Informed by Multi-omics Elucidates Pathogenesis and Therapeutic Targets in IgG4-related disease
Abstract Number: 2504

Medical potential traumatic events in patients with pediatric rheumatic disease
Abstract Number: 2894

Medical Student Health Navigators for High-Risk Patients with SLE at a Safety-Net Hospital: Educational Impact of a Year-Long Experiential Learning Program
Abstract Number: 0772

Medication Adherence in an Urban Safety-Net Rheumatology Clinic: Associations with Social Determinants and Clinical Factors
Abstract Number: 1707

Medication Adherence in SLE and RA: Prevalence and Predictors in a Nepali Tertiary Care Cohort
Abstract Number: 0578

Medication Burden Outperforms Baseline Demographics for Predicting Serious Adverse Events in Systemic JIA with Lung Disease: A CARRA Registry Analysis
Abstract Number: 2678

MEFV Zygosity Predicts Colchicine Drug Survival with a Resistance Profile Distinct from Mediterranean Cohorts: the Largest Chinese FMF Longitudinal Study
Abstract Number: 2468

Mental Health and Medication Adherence in Rheumatic Diseases: The Role of Depression and Anxiety
Abstract Number: 2469

Mental Health as a Possible Mediator of Autoimmune Disease in the Context of Adverse Childhood Experiences (ACEs)
Abstract Number: 1515

Mental Health Readiness in Youth with Rheumatic Disease: Barriers and Facilitators to Discussing Mental Health
Abstract Number: 0926

Mepolizumab versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis with Polyangiitis: Results from the Double-Blind, Double-Dummy, Randomized Controlled E-MERGE Trial
Abstract Number: 0716

Metabolic and Gene Expression Models Reveal Diet-Microbe and Microbe-Microbe Interactions Related to Uric Acid Consumption in Healthy and Disease States
Abstract Number: 1954

Metabolic Stress Licenses CD4+ T Cells to Produce Cytotoxic GzmB, Creating a Phenotypic Illusion and the Potential to Drive Tissue Sequestration in Arthritis
Abstract Number: 0725

Metabolic Workup After CPPD Diagnosis in Veterans: A Quality Improvement Gap Analysis (2010-2023)
Abstract Number: 0046

Metabolic-epigenetic regulation of interferon-responsive CD38 in systemic lupus erythematosus
Abstract Number: 1537

Methotrexate Adherence and Understanding Across Diverse Rheumatology Populations
Abstract Number: 1139

Methotrexate as a Glucocorticoid-Sparing Agent in Polymyalgia Rheumatica: An Updated Meta-analysis of Randomized Trials
Abstract Number: 0179

Methotrexate for Remission Maintenance Following Tocilizumab and Glucocorticoids Induction in Giant Cell Arteritis: The Randomized Phase II METEORITICS Trial
Abstract Number: 2371

Methotrexate vs Hydroxychloroquine in Sjögren Syndrome: Propensity-Matched Real-World Outcomes
Abstract Number: 1516

Metric properties and longitudinal performance of the Physician Global Assessment as single disease activity measure in Juvenile Dermatomyositis.
Abstract Number: 0133

Microbial Biomarkers in Lesional and Non-lesional Skin Across Autoimmune Diseases in the AMP AIM Consortium
Abstract Number: 1577

Microplastics Detected in Hip Joint Tissue, Synovial Fluid, and Blood in Patients Prior to Primary Total Hip Arthroplasty: A Pilot Study
Abstract Number: 1413

MicroRNA Expression Changes and Correlation with Clinical Response in Rheumatoid Arthritis Patients Switching Within the IL-6 inhibitor Class
Abstract Number: 0933

Microvascular Antiphospholipid Syndrome Is Associated with Subclinical Renal Involvement and Long-Term Kidney Function Decline
Abstract Number: 0987

Microvasculopathy-related Hemorrhagic Tissue Deposition of Iron in the Pathogenesis of Systemic Sclerosis
Abstract Number: 0915

Migration-dependent Synoviocyte-Endothelium Cross-talk in Rheumatoid Arthritis
Abstract Number: 2470

Mind matters: Prevalence, Determinants and Magnetic Resonance Spectroscopy findings of Cognitive Dysfunction in Indian Patients with Systemic Lupus Erythematosus
Abstract Number: 2725

Mind the Gap: Global snapshot of digital maturity in rheumatology care
Abstract Number: 0365

Minimal Disease Activity at 12 Months with Guselkumab and IL-17 Inhibitors in Psoriatic Arthritis: Results from the Global PsABIOnd Study
Abstract Number: 2337

Minimal disease activity in psoriatic arthritis among treatment-adherent patients: prevalence and determinants from a prospective South Asian cohort
Abstract Number: 1901

Minimal Residual Disease predicts five-year persistence in therapy of rituximab in Rheumatoid Arthritis and intercepts patients subsequently developing poly-refractory disease
Abstract Number: 0660

Minimal Residual Disease predicts Rituximab response in Idiopathic Inflammatory Myopathies: a novel paradigm based on Highly Sensitive Flow Cytometry with implications for advanced B-cell depleting therapies
Abstract Number: 1624

Minimally Invasive Ultrasound-guided Core Needle Biopsy of Inguinal Lymph Nodes: Data from a Rheumatologic Experience
Abstract Number: 2633

Minor salivary gland biopsy findings and clinical associations in patients with IgG4-related disease
Abstract Number: 2893

Missed Small-Joint Swelling During Learner Hand Examinations May Delay Inflammatory Arthritis Management
Abstract Number: 1625

Mixed NOD-like Receptor-Associated Autoinflammatory Disease
Abstract Number: 1626

Model-based PsO-PsA bridging for PsA dose selection: a case study of the IL-17 small molecule inhibitor JNJ-81241459
Abstract Number: 0123

Modified Simiao Decoction alleviates acute gouty arthritis by regulating the JAK3/STAT5 signaling pathway
Abstract Number: 0431

Modulation of Autoantibody-Driven Immune Pathways by Efgartigimod in Sjögren’s Disease: Translational Results from RHO
Abstract Number: 1093

Molecular and phenotypic architecture of rheumatoid factor production and its progression to rheumatoid arthritis
Abstract Number: 0134

Molecular Characterization of Heterogeneity in Sjögren’s Disease and Non-Sjögren’s Sicca Syndrome
Abstract Number: 1821

Molecular Heterogeneity in Preclinical Lupus: Distinct Longitudinal Proteomic Trajectories Preceding Disease Progression
Abstract Number: 1385

Molecular Overlap Between Sjögren’s Disease and Non-Sjögren’s Sicca Uncovered By High-Content Serum Proteomic Profiling
Abstract Number: 0684

Momelotinib in VEXAS syndrome: a preliminary report evaluation of safety and effectiveness
Abstract Number: 0536

Monitoring Complement Levels Throughout Pregnancy in Systemic Lupus Erythematosus Patients: Insights from the International Multicenter Prospective CORAL Study
Abstract Number: 1597

Monitoring Disease Activity in Dermatomyositis using Blood Microsampling: A Pilot Study
Abstract Number: 2261

Monitoring the Biological Response to Anifrolumab in Real World Setting Using Interferon Gene Signature Shows Signs of Therapy Resistance in Select SLE Patients
Abstract Number: 0579

Monogenic Type I Interferonopathies Presenting to Rheumatology: A Genetically Confirmed Case Series Highlighting Clinical Red Flags for Early Diagnosis
Abstract Number: 2568

More Severe Baseline Meniscal Pathology Predicts Greater, Sustained Response to IA TPX-100: A WORMS Analysis From A Randomized Trial
Abstract Number: 0391

More than Pain: Differences in Symptom Profile and Their Relation With Psoriatic Arthritis Activity in Male and Female Patients Enrolled in a Global Cohort Study
Abstract Number: 1006

Morphological Changes in Hippocampal Neuronal Dendrites in a Pristane-Induced Murine Lupus Model
Abstract Number: 2529

Mortality analysis in patients with IgG4-related disease: a long-term cohort study in China
Abstract Number: 1386

Mortality and Loss of Life Expectancy in Patients With Sjögren Disease in Sweden: A Population-Based Study From 2006 to 2022
Abstract Number: 0321

Mortality and Risk Factors Associated with Interstitial Lung Disease in Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study
Abstract Number: 0817

Mortality Attributed to Paget Disease of Bone as an Underlying Cause of Death in the United States, 2018-2024: A National Descriptive Analysis
Abstract Number: 2634

Mortality in Familial Mediterranean Fever: Comparison with the General Population and Identification of Independent Predictors of Survival
Abstract Number: 0685

Mortality post Lung Transplant in Systemic Autoimmune Rheumatic Disease Associated – Interstitial Lung Disease (SARD-ILD): A 20-Year analysis from the OPTN Cohort
Abstract Number: 2755

Mortality Trends and Disparities due to Inflammatory Polyarthropathies coexisting with sepsis in the United States: A 26-Year CDC Wonder Analysis From 1999 – 2024
Abstract Number: 2756

Mortality Trends and Disparities due to Systemic Connective Tissue Disorders coexisting with Diabetes Mellitus in the United States: A 26-Year CDC Wonder Analysis From 1999 – 2024
Abstract Number: 0731

Mortality Trends in Autoimmune Rheumatic Diseases and HIV Co-morbidity: A Multiple Cause of Death Analysis from the CDC Wonder Database, 1999-2020
Abstract Number: 1140

Mortality, Causes of Death, and Prognostic Performance of the Five-Factor Score in Contemporary Polyarteritis Nodosa
Abstract Number: 0686

Mortality, Respiratory Failure, and Transplant Outcomes in Connective Tissue Disease-Associated Versus Cryptogenic Organizing Pneumonia: A Propensity Score-Matched Analysis
Abstract Number: 0818

Most US Adults with Arthritis Suffer from Cardiovascular-Kidney-Metabolic Syndrome: An Analysis of NHANES from 2001-2020
Abstract Number: 1350

MRI-Detected Axial Inflammation In Newly Diagnosed Psoriatic Arthritis
Abstract Number: 1082

MRT-8102, an Orally Bioavailable NEK7-Selective Molecular Glue Degrader, Suppresses NLRP3 Inflammasome Activation and Demonstrates Efficacy in a Rabbit Model of Gouty Arthritis
Abstract Number: 1992

Mucosal-associated invariant T (MAIT) cells coordinate IL-15-dependent regulatory T cell responses to resolve inflammation in cutaneous lupus
Abstract Number: 2022

Multi Omics Integration Reveals Treatment and Plaque Dependent Molecular Signatures in Biologic Naïve Rheumatoid Arthritis Patients Receiving csDMARDs, TNF Inhibitors or Baricitinib
Abstract Number: 0432

Multi-Ancestry Genome-Wide Association Study of Sjögren’s Disease Identifies Novel Risk Loci
Abstract Number: 0988

Multi-Compartment Single-Cell Profiling Identifies Aberrant FCGR3A⁺ Non-Classical Monocyte Recruitment and Differentiation Failure at SSc Wound Sites
Abstract Number: 2075

Multi-Cytokine Profiles in Blood and Tears Predict Subclinical Disease Activity in Aqueous Humor of Patients with Chronic Autoimmune Uveitis
Abstract Number: 0047

Multi-lineage immune remodeling following CD3xCD19 T-cell engagement in active systemic lupus erythematosus: single-cell genomic results from a Phase I investigator initiated trial
Abstract Number: 1937

Multi-modal analysis reveals a perivascular signature of endothelial-immune remodelling in regressive skin fibrosis in SSc
Abstract Number: 1414

Multi-Modal Molecular Profiling Identifies Pharmacodynamic Response Modules Following PD-1 Agonist Treatment in Patients With Rheumatoid Arthritis
Abstract Number: 0098

Multi-Omic Signatures Identify Sex-Specific Cardiovascular Risk Endotypes in Rheumatoid Arthritis
Abstract Number: 2065

Multi-Omics Characterization of Yao Syndrome Identifies Three Pathophysiological Axes and Disease-Specific Divergence from Blau Syndrome
Abstract Number: 1110

Multi-Omics Integration of Data Reveals Lysophosphatidic Acid and Metabolic Pathway Signatures in B Cells and Immune Macroenvironment from Sjögren’s Disease patients
Abstract Number: 2013

Multi-omics Integration of Synovial Fluid Markers Identifies Key Pathways Differentiating Psoriatic Arthritis from Osteoarthritis
Abstract Number: 2837

Multi-Scale Computational Dissection of a Pro-Inflammatory Complement-Macrophage Interaction Circuit in Rheumatoid Arthritis Tissue
Abstract Number: 1891

Multi-State Modeling of Patient Acceptable Symptom State Transitions for Pain and Function in Individuals with Radiographic Knee Osteoarthritis in the Multicenter Osteoarthritis Study
Abstract Number: 2215

Multicenter Real-World Registry of Anifrolumab (ANIFRO-REU) in Systemic Lupus Erythematosus: Effectiveness in Patients with Articular and Cutaneous Manifestations with up to 12 Months of Follow-up
Abstract Number: 0687

Multicenter Validation of the 23-Valent Polysaccharide Pneumococcal Vaccine-Induced Skin Pathergy Test in Behçet’s Disease
Abstract Number: 2844

Multidimensional Disease State Trajectories Identity Remission Heterogeneity and Refractory Lupus Nephritis Risk in Systemic Lupus Erythematosus
Abstract Number: 0366

Multidomain Efficacy and Safety of IL-17 Inhibitors Versus Adalimumab in Biologic-Naïve PsA: A Systematic Review and Meta-Analysis of Head-to-Head Trials
Abstract Number: 2300

Multidrug Exposure May Trigger Iatrogenic Treatment Failure in Spondyloarthritis: Insights from Historic Real-World Data of the Leeds Specialist Spondyloarthritis Service
Abstract Number: 0848

Multilevel Physician-Perceived Influences on Reproductive Health Counseling in SLE: An Adapted Social Ecological Model Analysis
Abstract Number: 0240

Multimodal Assessment of Central Neurological Involvement in Systemic Sclerosis: Is There a Neuropsychiatric Systemic Sclerosis?
Abstract Number: 0150

Multimodal Single-Cell Profiling Reveals Distinct Systemic Immune Remodeling Following Ocrelizumab vs Ofatumumab Therapy
Abstract Number: 2726

Multimorbidity Phenotypes in Adults with Arthritis: A Latent Class and Association Rule Mining Analysis of Electronic Health Records
Abstract Number: 2956

Multiple Vertebral Fracture as an adverse effect in patients with poor adherence to Denosumab treatment. Retrospective study.
Abstract Number: 0497

Muscle Quality and Architecture by Ultrasound Better Reflect Physical Performance Than DXA-Derived Muscle Mass in Women With Rheumatoid Arthritis
Abstract Number: 2635

Musculoskeletal and Functional Symptoms of HPP May First Appear in Adulthood
Abstract Number: 1487

Musculoskeletal Exam Teaching for Residents in Pediatric Rheumatology: A North American Needs Assessment
Abstract Number: 0615

Musculoskeletal Pain in Adult Mastocytosis: A Descriptive Cohort Study
Abstract Number: 2695

Mycophenolate Exposure and Radiologic Worsening in Connective Tissue Disease-Associated Interstitial Lung Disease: A Paired High-Resolution CT Cohort Study
Abstract Number: 0989

Mycophenolate Mofetil Shows Differential Modulation of Skin Gene Expression Across Autoantibody Subgroups of Diffuse Cutaneous Systemic Sclerosis
Abstract Number: 2595

Myocardial Involvement In Idiopathic Inflammatory Myopathies